Skip to main content
OpenTrials

Clinical trial condition

Triple Negative Breast Cancer

Explore clinical trials studying Triple Negative Breast Cancer. Study availability and eligibility vary by location and protocol.

294 public trials 113 recruiting studies
Refine in advanced search Browse all conditions

Triple Negative Breast Cancer trial results

Recruiting

NeoAdj. Therapy Comparing Sacituzumab Govitecan (SG) vs. SG+Pembrolizumab in Low-risk, Triple-neg. EBC (ADAPT-TN-III)

NCT06081244

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • Stadtklinik Baden-Baden / Brustzentrum Baden-Baden, Baden-Wurttemberg, Germany
  • Kliniken Böblingen Böblingen, Baden-Wurttemberg, Germany
  • Praxis für interdisziplinäre Onkologie & Hämatologie Freiburg im Breisgau, Baden-Wurttemberg, Germany
  • SLK Kliniken Heilbronn, Frauenklinik Heilbronn, Baden-Wurttemberg, Germany
View all 42 locations
View Trial Details
Recruiting

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

NCT05902988

Conditions
Advanced Solid Tumor, Breast Diseases, Breast Neoplasms, +34 more
Locations
  • University of Southern California Los Angeles, California, United States
  • Hoag Memorial Hospital Newport Beach, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Yale Cancer Center New Haven, Connecticut, United States
View all 14 locations
View Trial Details
Recruiting

Modi-1 Moditope in Breast, Head and Neck, Ovarian, or Renal Cancer

NCT05329532

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +25 more
Locations
  • Brighton and Sussex University Hospital Brighton, Default, United Kingdom
  • Velindre Cancer Centre Cardiff, Default, United Kingdom
  • Edinburgh Cancer Centre (NHS Lothian) Edinburgh, Default, United Kingdom
  • Royal Surrey NHS Foundation Guildford, Default, United Kingdom
View all 16 locations
View Trial Details

Related conditions